Holen Sie sich die Stockscreener-App
2.54
8.63%
-0.24
Vorhandelsmarkt:
2.65
0.11
+4.33%
Schlusskurs vom Vortag:
$2.78
Offen:
$2.81
24-Stunden-Volumen:
1.34M
Relative Volume:
0.14
Marktkapitalisierung:
$40.66M
Einnahmen:
$1.38M
Nettoeinkommen (Verlust:
$-179.05M
KGV:
-0.4137
EPS:
-6.14
Netto-Cashflow:
$-155.03M
1W Leistung:
+0.40%
1M Leistung:
-27.84%
6M Leistung:
+54.88%
1J Leistung:
+393.20%
1-Tages-Spanne:
$2.515
$2.81
1-Wochen-Bereich:
$2.42
$2.87
52-Wochen-Spanne:
$0.16
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
Firmenname
Bioxcel Therapeutics Inc
Sektor
Branche
Telefon
203-643-8060
Adresse
555 LONG WHARF DRIVE, NEW HAVEN, CT
Vergleichen Sie BTAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
2.54 | 54.62M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-21 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-15 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-07-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-03-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-01 | Hochstufung | Goldman | Sell → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-06 | Bestätigt | BofA Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-30 | Eingeleitet | Goldman | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-04 | Eingeleitet | Guggenheim | Buy |
| 2020-04-01 | Eingeleitet | BofA/Merrill | Buy |
| 2020-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Bioxcel Therapeutics Inc Aktie (BTAI) Neueste Nachrichten
Published on: 2025-10-12 22:14:31 - newser.com
BioXcel Therapeutics announces pricing of $7M public offering - MSN
Why BioXcel Therapeutics, Inc. (BTAI) Soared Last Week - MSN
How BioXcel Therapeutics Inc. (BX20) stock reacts to stronger dollarWeekly Stock Analysis & Low Risk Profit Maximizing Plans - newser.com
BioXcel Therapeutics Receives Positive FDA Feedback - MSN
Sentiment analysis tools applied to BioXcel Therapeutics Inc.Weekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Is BioXcel Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Movers & High Conviction Trade Alerts - newser.com
BioXcel Therapeutics Inc. stock outlook for YEARTrade Signal Summary & Safe Capital Investment Plans - newser.com
BioXcel Therapeutics Inc. stock daily chart insights2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
What drives BioXcel Therapeutics Inc BX20 stock pricePrice Action Analysis & Double Or Triple Wealth - earlytimes.in
How BioXcel Therapeutics Inc. (BX20) stock responds to bond marketJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
Will BioXcel Therapeutics Inc. stock recover faster than peersQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
Is BioXcel Therapeutics Inc. stock reversal real or fakeEarnings Recap Summary & Growth Focused Stock Pick Reports - newser.com
BioXcel Therapeutics Inc. stock chart pattern explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com
BioXcel Investors Advance Suit Over FDA Study Compliance Issues - Bloomberg Law News
What analysts say about BioXcel Therapeutics Inc stockMean Reversion Trades & Market Monitoring and Alerts - earlytimes.in
BioXcel Therapeutics Inc Stock Analysis and ForecastSell Signals and Alerts & Control Your Emotions With Discipline Tools - earlytimes.in
User - FinancialContent
BioXcel Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
Volume spikes in BioXcel Therapeutics Inc. stock – what they meanJuly 2025 Trends & Intraday High Probability Alerts - newser.com
Real time scanner hits for BioXcel Therapeutics Inc. explained2025 Volatility Report & Weekly High Return Opportunities - newser.com
Fundamentals Check: Is BioXcel Therapeutics Inc benefiting from interest rate changesWeekly Trade Report & Technical Analysis for Trade Confirmation - خودرو بانک
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Up 166.4% in August - MarketBeat
ETF Watch: How cyclical is BioXcel Therapeutics Incs revenue streamAnalyst Upgrade & Risk Controlled Stock Pick Alerts - خودرو بانک
Aug Reactions: How cyclical is BioXcel Therapeutics Incs revenue streamJuly 2025 Trends & Reliable Price Breakout Alerts - khodrobank.com
BioXcel Therapeutics regains Nasdaq compliance after MVLS issue By Investing.com - Investing.com South Africa
BioXcel Therapeutics regains compliance with Nasdaq market value of listed securities requirements - MarketScreener
BioXcel Therapeutics Regains Compliance With Nasdaq Market Value of Listed Securities Requirements - 富途牛牛
BioXcel Therapeutics (BTAI) Regains Nasdaq Compliance - GuruFocus
BioXcel Therapeutics regains Nasdaq compliance after MVLS issue - Investing.com
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bioxcel Therapeutics Inc-Aktie (BTAI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mehta Vimal | CEO and President |
Dec 16 '24 |
Sale |
0.36 |
3,117 |
1,131 |
59,605 |
| Steinhart Richard I | Chief Financial Officer |
Dec 16 '24 |
Sale |
0.36 |
577 |
207 |
20,932 |
| Rodriguez Javier | See Remarks |
Dec 16 '24 |
Sale |
0.36 |
430 |
153 |
24,423 |
| Yocca Frank | Chief Scientific Officer |
Dec 16 '24 |
Sale |
0.35 |
430 |
152 |
28,931 |
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):